A detailed history of Private Advisory Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Private Advisory Group LLC holds 1,704 shares of ABBV stock, worth $282,795. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,704
Holding current value
$282,795
% of portfolio
0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $272,333 - $310,298
1,704 New
1,704 $310,000
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $174,270 - $208,996
1,260 New
1,260 $203,000
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $236,844 - $301,106
1,721 New
1,721 $264,000
Q1 2018

May 01, 2018

SELL
$92.01 - $123.21 $351,938 - $471,278
-3,825 Closed
0 $0
Q4 2017

Jan 30, 2018

BUY
$89.56 - $98.21 $342,567 - $375,653
3,825
3,825 $370,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Private Advisory Group LLC Portfolio

Follow Private Advisory Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisory Group LLC with notifications on news.